K Health, a startup combining a free symptom checker with text-based telehealth and virtual primary care, has announced $132 million Series E – its third major raise within the course of a year.
GGV Capital, Valor Equity Partners and Kaiser Permanente pension fund headlined the raise, with GGV Managing Partner Hans Tung and Valor founder and CEO Antonio Gracias joining K Health's board. Other...
Poland-based AI platform for preliminary diagnosis, Infermedica has announced the launch of its new feature, Specialist Recommender.
The platform was developed over six months, in response to clients’ requests to provide patients with more tailored advice in addition to initial triaging suggestions.
The function enables healthcare and insurance providers to provide patients with a recommendation...
Founded by a medical doctor and an engineer in 2017, Japanese medtech startup Ubie which focuses on AI-based applications announced that it has raised $18.7M (JPY2 billion) in Series B funding led by SUZUKEN CO., LTD., a listed pharmaceutical distributor company in Japan. The pharma company has also entered into a strategic partnership with Ubie.
The startup will use the fresh funds to scale up...
U.K. and U.S. residents who reported a loss of smell and taste into a COVID-19 symptom-tracker app more often tested positive for the infection, according to a study published yesterday in Nature.
The COVID Symptom Study app was developed by health technology company Zoe Global with help from King's College London and Massachusetts General Hospital. It launched in the U.K. and the U.S. in late...
K Health, a free symptom checking app with optional paid telehealth features, announced this morning a $48 million Series C round led by 14W and Mangrove Capital. Anthem, Lerer Hippeau, Primary Ventures and other unnamed backers also contributed.
WHAT THEY DO
Using a dataset comprised of physician notes, lab results, treatments, prescriptions, prior visits and other anonymized interactions, K...
